Jean‐Claude Bensa - Concepedia

Author

Jean‐Claude Bensa

Also Known As

J BENSA, J C Bensa, J. Arvieux, J. C. Bensa, J.-C. Bensa, J.C Bensa, J.C. Bensa, J.Cl. Bensa, JEAN-CLAUDE BENSA, JEAN‐CLAUDE BENSA

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Inserm Institut National de la Transfusion Sanguine Centre Hospitalier Universitaire de Grenoble CEA Grenoble Commissariat à l'Énergie Atomique et aux Énergies Alternatives

About

Jean‐Claude Bensa is an author at Inserm specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	628
2	Cell Biology	5	5	295
3	Health Sciences	1	1	16
4	Public Health	1	1	16
5	Biochemistry	1	1	49

Jean‐Claude Bensa

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Development of an ELISA for Autoantibodies to Prothrombin Showing their Prevalence in Patients with Lupus Anticoagulants J Arvieux, Luc Darnige, Claudine Caron, Thrombosis and Haemostasis	1995	211
Survival of DNA HLA-DR typed and matched cadaver kidney transplants Gerhard Opelz, Joannis Mytilineos, Sabine Scherer, The Lancet UrologyTransplantationDna Hla-drHuman Leukocyte AntigenKidney Transplant	1991	200
Membrane cell permeabilisation with saponin and multiparametric analysis by flow cytometry Marie Christine Jacob, Mireille Favre, Jean‐Claude Bensa Cytometry Immunocytochemical TechniqueImmunologyPathologyImmunophenotypingFlow Cell	1991	144
Biosynthesis <i>in vitro</i> of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes Jean‐Claude Bensa, A. Reboul, Maurice G. Colomb Biochemical Journal	1983	128
Tumor B Cells From Non-Hodgkin's Lymphoma Are Resistant to CD95 (Fas/Apo-1)–Mediated Apoptosis Joël Plumas, Marie‐Christine Jacob, Laurence Chaperot, Blood	1998	117
Characterization of the C1q receptor on a human macrophage cell line, U937 J Arvieux, A. Reboul, Jean‐Claude Bensa, Biochemical Journal Proteinlipid InteractionImmunocytochemical TechniqueImmunologyC1q ReceptorImmunologic Mechanism	1984	49
Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin’s lymphomas Laurence Chaperot, Joël Plumas, Marie‐Christine Jacob, Experimental Hematology Lymphoid NeoplasiaCancer ImmunosurveillanceMalignant B CellsFunctional ExpressionMalignant Blood Disorder	1999	48
DNA HLA-DR TYPING RESULTS OF 4000 KIDNEY TRANSPLANTS Joannis Mytilineos, SABINE SCHERER, H. Dunckley, Transplantation	1993	47
BENEFICIAL EFFECT OF ONE HLA HAPLO- OR SEMI-IDENTICAL TRANSFUSION VERSUS THREE UNTYPED BLOOD UNITS ON ALLOIMMUNIZATION AND ACUTE REJECTION EPISODES IN FIRST RENAL ALLOGRAFT RECIPIENTS François Bayle, Dominique Masson, Philippe Zaoui, Transplantation	1995	47
Malignant B lymphocytes from non‐Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: An important role of co‐stimulatory molecules CD80 (B7‐1) and CD86 (B7‐2) in stimulation by tumor cells Joël Plumas, Laurence Chaperot, Marie‐Christine Jacob, European Journal of Immunology	1995	45

Page 1